Potassium channel (Voltage-gated or ligand-gated) (K+ channel)

Potassium channels are a diverse group of transmembrane proteins that selectively facilitate the transport of potassium ions across cell membranes [IUPHAR/BPS Guide to Pharmacology]. They are categorized into several families based on their gating mechanisms, most notably voltage-gated (Kv) and ligand-gated (such as calcium-activated or ATP-sensitive) channels [StatPearls, 2023]. These channels are essential for maintaining the resting membrane potential and regulating the repolarization phase of action potentials in neurons and muscle cells [PubMed, PMID: 29733311]. In the cardiovascular system, they control heart rate and vascular tone, while in the pancreas, they regulate insulin secretion [NIH, 2023]. Mutations or dysfunction in these channels lead to various channelopathies, including Long QT syndrome, epilepsy, and neonatal diabetes [PubMed, PMID: 30256717]. Therapeutic agents targeting these channels include Class III antiarrhythmics, which block channels to prolong action potentials, and sulfonylureas, which inhibit ATP-sensitive channels to stimulate insulin release [PubChem, 2024]. Due to their ubiquitous expression and critical physiological roles, drugs modulating these channels must be carefully designed to avoid serious side effects like cardiac arrhythmias or metabolic disturbances [StatPearls, 2023].

Other names

K channelK+ channelVoltage-dependent potassium channelLigand-dependent potassium channelPotassium ion channel

Drugs targeting these channels act as either pore blockers, which inhibit the flow of potassium ions to prolong action potentials or reduce cell excitability, or as channel openers (activators), which enhance potassium conductance to hyperpolarize the membrane and reduce excitability [StatPearls, 2023; PubChem, 2024].